Canada markets closed

Interpace Biosciences, Inc. (IDXG)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.5196+0.1496 (+10.92%)
At close: 03:21PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
919
802
-21,958
-14,943
-26,451
-
Depreciation & amortization
1,264
1,601
3,502
5,374
5,501
-
Deferred income taxes
-
0
-93
38
37
-
Stock based compensation
517
630
1,304
1,368
2,242
-
Change in working capital
-968
-83
-3,991
-1,131
5,227
-
Accounts receivable
-317
49
-133
2,148
1,725
-
Accounts Payable
-219
489
-735
-1,817
-198
-
Other working capital
2,165
3,319
-8,014
-9,073
-15,554
-
Other non-cash items
966
839
1,147
715
60
-
Net cash provided by operating activites
2,598
3,789
-7,692
-8,719
-13,979
-
Cash flows from investing activities
Investments in property, plant and equipment
-433
-470
-322
-354
-1,575
-
Acquisitions, net
-
-
-
-
0
-13,829
Net cash used for investing activites
-50
-87
6,206
-315
-1,575
-
Cash flows from financing activities
Debt repayment
-2,800
-2,500
0
-7,924
0
-
Common stock issued
-
0
108
335
434
-
Common stock repurchased
-
-32
-108
0
-52
-
Other financing activites
-
-2,500
-
-435
-
-
Net cash used privided by (used for) financing activities
-5,332
-5,032
3,000
8,976
16,605
-
Net change in cash
-2,784
-1,330
1,514
-58
1,051
-
Cash at beginning of period
5,596
4,828
3,314
3,372
2,321
-
Cash at end of period
2,812
3,498
4,828
3,314
3,372
-
Free Cash Flow
Operating Cash Flow
2,598
3,789
-7,692
-8,719
-13,979
-
Capital Expenditure
-433
-470
-322
-354
-1,575
-
Free Cash Flow
2,165
3,319
-8,014
-9,073
-15,554
-